Concentrix [CNXC] vs Parsons [PSN] Detailed Stock Comparison

Concentrix

Parsons
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Concentrix wins in 9 metrics, Parsons wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Concentrix | Parsons | Better |
---|---|---|---|
P/E Ratio (TTM) | 10.22 | 39.23 | Concentrix |
Price-to-Book Ratio | 0.69 | 3.71 | Concentrix |
Debt-to-Equity Ratio | 111.13 | 56.60 | Parsons |
PEG Ratio | 0.02 | -1.96 | Parsons |
EV/EBITDA | 5.26 | 19.47 | Concentrix |
Profit Margin (TTM) | 3.25% | 3.70% | Parsons |
Operating Margin (TTM) | 5.92% | 6.24% | Parsons |
EBITDA Margin (TTM) | 5.92% | 6.24% | Parsons |
Return on Equity | 7.43% | 12.44% | Parsons |
Return on Assets (TTM) | 3.85% | 4.96% | Parsons |
Free Cash Flow (TTM) | $428.73M | $474.39M | Parsons |
Dividend Yield | 3.51% | N/A | N/A |
1-Year Return | -0.83% | -17.49% | Concentrix |
Price-to-Sales Ratio (TTM) | 0.31 | 1.40 | Concentrix |
Enterprise Value | $7.48B | $10.52B | Parsons |
EV/Revenue Ratio | 0.77 | 1.57 | Concentrix |
Gross Profit Margin (TTM) | N/A | 21.99% | N/A |
Revenue per Share (TTM) | $153 | $63 | Concentrix |
Earnings per Share (Diluted) | $4.72 | $2.23 | Concentrix |
Beta (Stock Volatility) | 0.55 | 0.64 | Concentrix |
Concentrix vs Parsons Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Concentrix | -1.49% | -0.61% | -9.52% | -16.13% | 0.74% | 9.19% |
Parsons | 0.97% | 7.89% | 17.77% | 18.82% | 50.02% | -2.41% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Concentrix | -0.83% | -59.61% | -40.58% | -40.58% | -40.58% | -40.58% |
Parsons | -17.49% | 117.99% | 164.70% | 184.84% | 184.84% | 184.84% |
News Based Sentiment: Concentrix vs Parsons
Concentrix
News based Sentiment: MIXED
Concentrix reported mixed Q3 results with a revenue beat but EPS and EBITDA misses, leading to lowered guidance. However, the company continues to invest in AI and return capital to shareholders, creating a complex investment narrative with both positive and negative elements.
Parsons
News based Sentiment: MIXED
October was a mixed month for Parsons, marked by significant contract wins and a strategic acquisition that bolster long-term growth prospects, but tempered by expectations of a year-over-year earnings decline. The positive analyst sentiment and insider activity provide some reassurance, but the upcoming earnings report will be crucial for investors.
Performance & Financial Health Analysis: Concentrix vs Parsons
Metric | CNXC | PSN |
---|---|---|
Market Information | ||
Market Cap | $3.10B | $9.34B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 1,434,880 | 1,034,329 |
90 Day Avg. Volume | 944,133 | 1,127,460 |
Last Close | $47.54 | $88.33 |
52 Week Range | $36.28 - $66.00 | $54.56 - $114.68 |
% from 52W High | -27.97% | -22.98% |
All-Time High | $208.48 (Feb 07, 2022) | $114.68 (Nov 04, 2024) |
% from All-Time High | -77.20% | -22.98% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | -0.05% |
Quarterly Earnings Growth | 4.30% | -0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.03% | 0.04% |
Operating Margin (TTM) | 0.06% | 0.06% |
Return on Equity (TTM) | 0.07% | 0.12% |
Debt to Equity (MRQ) | 111.13 | 56.60 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $69.83 | $23.56 |
Cash per Share (MRQ) | $5.63 | $3.85 |
Operating Cash Flow (TTM) | $648.78M | $573.81M |
Levered Free Cash Flow (TTM) | $3.74B | $379.45M |
Dividends | ||
Last 12-Month Dividend Yield | 3.51% | N/A |
Last 12-Month Dividend | $1.68 | N/A |
Valuation & Enterprise Metrics Analysis: Concentrix vs Parsons
Metric | CNXC | PSN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 10.22 | 39.23 |
Forward P/E | 3.92 | 22.49 |
PEG Ratio | 0.02 | -1.96 |
Price to Sales (TTM) | 0.31 | 1.40 |
Price to Book (MRQ) | 0.69 | 3.71 |
Market Capitalization | ||
Market Capitalization | $3.10B | $9.34B |
Enterprise Value | $7.48B | $10.52B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.77 | 1.57 |
Enterprise to EBITDA | 5.26 | 19.47 |
Risk & Other Metrics | ||
Beta | 0.55 | 0.64 |
Book Value per Share (MRQ) | $69.83 | $23.56 |
Financial Statements Comparison: Concentrix vs Parsons
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CNXC | PSN |
---|---|---|
Revenue/Sales | $2.37B | $1.58B |
Cost of Goods Sold | $1.52B | $1.24B |
Gross Profit | $855.90M | $348.35M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $168.87M | $96.30M |
EBITDA | $334.50M | $130.34M |
Pre-Tax Income | $100.79M | $89.18M |
Income Tax | $30.54M | $18.69M |
Net Income (Profit) | $70.26M | $70.49M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CNXC | PSN |
---|---|---|
Cash & Equivalents | $308.00M | $269.75M |
Total Current Assets | $2.96B | $2.40B |
Total Current Liabilities | $1.79B | $1.87B |
Long-Term Debt | $4.90B | $893.53M |
Total Shareholders Equity | $4.03B | $2.55B |
Retained Earnings | $1.24B | $487.63M |
Property, Plant & Equipment | $0 | $269.27M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CNXC | PSN |
---|---|---|
Operating Cash Flow | $231.10M | $125.40M |
Capital Expenditures | $-55.79M | $0 |
Free Cash Flow | $180.74M | $-25.26M |
Debt Repayment | $-1.45B | $-174.38M |
Common Stock Repurchase | $-46.82M | $-25.00M |
Short Interest & Institutional Ownership Analysis
Metric | CNXC | PSN |
---|---|---|
Shares Short | 7.66M | 6.28M |
Short Ratio | 12.27 | 6.89 |
Short % of Float | 0.15% | 0.12% |
Average Daily Volume (10 Day) | 1,434,880 | 1,034,329 |
Average Daily Volume (90 Day) | 944,133 | 1,127,460 |
Shares Outstanding | 64.24M | 106.78M |
Float Shares | 35.03M | 53.70M |
% Held by Insiders | 0.16% | 0.01% |
% Held by Institutions | 0.98% | 1.06% |
Dividend Analysis & Yield Comparison: Concentrix vs Parsons
Metric | CNXC | PSN |
---|---|---|
Last 12-Month Dividend | $1.68 | N/A |
Last 12-Month Dividend Yield | 3.51% | N/A |
3-Year Avg Annual Dividend | $1.33 | N/A |
3-Year Avg Dividend Yield | 0.49% | N/A |
3-Year Total Dividends | $4.00 | N/A |
Ex-Dividend Date | Oct 24, 2025 | N/A |